These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36401355)

  • 1. HIV-1 Subtype C Vpr Amino Acid Residue 45Y and Specific Conserved Fragments Are Associated with Neurocognitive Impairment and Markers of Viral Load.
    Ruhanya V; Jacobs GB; Paul RH; Joska JA; Seedat S; Nyandoro G; Glashoff RH; Engelbrecht S
    AIDS Res Hum Retroviruses; 2023 Apr; 39(4):166-175. PubMed ID: 36401355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    Kamori D; Hasan Z; Ohashi J; Kawana-Tachikawa A; Gatanaga H; Oka S; Ueno T
    J Med Virol; 2017 Jan; 89(1):123-129. PubMed ID: 27328918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment.
    Ruhanya V; Jacobs GB; Paul RH; Joska JA; Seedat S; Nyandoro G; Glashoff RH; Engelbrecht S
    J Neurovirol; 2022 Jun; 28(3):392-403. PubMed ID: 35394614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV.
    Ruhanya V; Jacobs GB; Nyandoro G; Paul RH; Joska JA; Seedat S; Glashoff RH; Engelbrecht S
    J Neurovirol; 2020 Dec; 26(6):920-928. PubMed ID: 32737863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC.
    Du L; Wang L; Yu T; Xin R; Meng Z
    Curr HIV Res; 2020; 18(3):165-171. PubMed ID: 32096745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
    Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
    J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.
    de Silva S; Planelles V; Wu L
    PLoS One; 2012; 7(5):e35385. PubMed ID: 22570689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Analysis of HIV-1
    Love M; Samora L; Barker D; Zukosky P; Kummet N; Ahmad A; Bernhardt D; Tripathi M; Klotz S; Ahmad N
    Curr HIV Res; 2022; 20(4):309-320. PubMed ID: 35792120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.
    Nie Z; Bergeron D; Subbramanian RA; Yao XJ; Checroune F; Rougeau N; Cohen EA
    J Virol; 1998 May; 72(5):4104-15. PubMed ID: 9557700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Vpr redirects host ubiquitination pathway.
    Arora S; Verma S; Banerjea AC
    J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
    Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal Expression Patterns, and Not Viral Burst Sizes, Predict the Effects of Vpr on HIV-1 Proviral Populations in Jurkat Cells.
    Atindaana E; Kissi-Twum A; Emery S; Burnett C; Pitcher J; Visser M; Kidd JM; Telesnitsky A
    mBio; 2022 Apr; 13(2):e0374821. PubMed ID: 35384697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case-control study.
    McMullen K; Bateman K; Stanley A; Combrinck M; Engelbrecht S; Bryer A
    J Neurovirol; 2021 Feb; 27(1):137-144. PubMed ID: 33462790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of viral protein R amino acid substitutions on clinical outcomes in people living with HIV: A systematic review.
    Asia LK; Jansen Van Vuren E; Williams ME
    Eur J Clin Invest; 2023 May; 53(5):e13943. PubMed ID: 36579370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpr-Induced Proinflammatory Response and Apoptosis Are Mediated through the Sur1-Trpm4 Channel in Astrocytes.
    Li G; Makar T; Gerzanich V; Kalakonda S; Ivanova S; Pereira EFR; Andharvarapu S; Zhang J; Simard JM; Zhao RY
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and phylogenetic analysis of HIV type 1 vpr sequences of South African strains.
    Romani B; Glashoff R; Engelbrecht S
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):357-62. PubMed ID: 19271970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro.
    Ayyavoo V; Mahalingam S; Rafaeli Y; Kudchodkar S; Chang D; Nagashunmugam T; Williams WV; Weiner DB
    J Leukoc Biol; 1997 Jul; 62(1):93-9. PubMed ID: 9225999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
    Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
    DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.